Literature DB >> 1684171

Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.

R de Jong1, P Stokkers, E Lamme, J M Kool, F Borst, M Brouwer, F Miedema, R A van Lier.   

Abstract

It was analysed to what extent the functional T-cell responses that result from T-cell receptor (TcR)/CD3 triggering differ from responses that are induced after simultaneous ligation of CD2 and CD28 accessory molecules. To allow a quantitative comparison of these activation pathways, purified lymphocytes were stimulated with either graded densities of immobilized anti-CD3 monoclonal antibodies (mAb) or with increasing amounts of anti-CD28 mAb in the presence of a constant concentration of anti-CD2 mAb. Both activation systems were sensitive to the regulatory properties of CD11a/CD18 molecules. T-cell stimulation via CD2/CD28 molecules induced a more potent release of interleukin-2 (IL-2) and more pronounced T helper (Th) cell responses than T-cell stimulation via the TcR/CD3 complex, whereas CD25 expression was more readily initiated after T-cell activation via the TcR/CD3 complex. Optimal Th cell differentiation was detected under conditions of suboptimal receptor occupancy whereas, in contrast, optimal cytolytic T lymphocyte (CTL) differentiation required optimal TcR/CD3 or CD2/CD28 engagement. The findings indicate that T-cell differentiation can be influenced in a qualitative manner by the strength of the activation signal provided, and suggest that antigen-specific T-cell responses might be regulated in a quantitative manner through CD2 and CD28 accessory molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684171      PMCID: PMC1384590     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

1.  T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways.

Authors:  R A Van Lier; M Brouwer; E D De Groot; I Kramer; L A Aarden; A J Verhoeven
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

2.  Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase.

Authors:  L E Samelson; M C Fletcher; J A Ledbetter; C H June
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

Authors:  G J Freeman; A S Freedman; J M Segil; G Lee; J F Whitman; L M Nadler
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1.

Authors:  M L Dustin; T A Springer
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

6.  The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.

Authors:  B E Bierer; S L Schreiber; S J Burakoff
Journal:  Eur J Immunol       Date:  1991-02       Impact factor: 5.532

7.  Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription.

Authors:  R A Gruters; S A Otto; B J Al; A J Verhoeven; C L Verweij; R A Van Lier; F Miedema
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

8.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.

Authors:  J D Fraser; B A Irving; G R Crabtree; A Weiss
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

9.  Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.

Authors:  R de Jong; M Brouwer; F Miedema; R A van Lier
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

10.  The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

Authors:  L Koulova; E A Clark; G Shu; B Dupont
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  3 in total

1.  Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies.

Authors:  M J Flens; W M Mulder; H Bril; M B von Blomberg van de Flier; R J Scheper; R A van Lier
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

2.  Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment.

Authors:  W M Mulder; H Koenen; A J van de Muysenberg; E Bloemena; J Wagstaff; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

3.  A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer.

Authors:  Xi Li; Rouzheng Wang; Peiwen Fan; Xuan Yao; Ling Qin; Yanchun Peng; Miaomiao Ma; Neil Asley; Xuimei Chang; Yaning Feng; Yunhui Hu; Yonghong Zhang; Chris Li; Gregory Fanning; Stephanie Jones; Clare Verrill; David Maldonado-Perez; Paul Sopp; Craig Waugh; Stephen Taylor; Simon Mcgowan; Vincenzo Cerundolo; Christopher Conlon; Andrew McMichael; Shichun Lu; Xiyan Wang; Ning Li; Tao Dong
Journal:  Front Oncol       Date:  2019-10-25       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.